Cytocom, Inc.
Records under this name other than the patents Cytocom, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 9 of 9 · Back to Cytocom, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,242,057 | Methods for Identifying Modulators of Apoptosis Formerly held In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 10,034,926 | Use of Toll-Like Receptor Agonist for Treating Cancer Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,265,390 | Use of Toll-Like Receptor Agonist for Treating Cancer Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,780,152 | Use of Toll-Like Receptor Agonist for Treating Cancer Formerly held In force (reinstated) · Medium confidence | In force (reinstated) | Medium confidence | |
| US 9,376,473 | Use of Toll-Like Receptor Agonist for Treating Cancer Formerly held In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 11,628,201 | Use of Toll-Like Receptor Agonist for Treating Cancer Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,183,056 | Methods and Compositions for the Treatment of Radiation-Related Disorders Formerly held In force · High confidence | In force | High confidence | |
| US 10,857,200 | Methods and Compositions for the Treatment of Radiation-Related Disorders Formerly held In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 11,419,865 | Method for Inducing a Sustained Immune Response Lapsed on the fee record Ended Aug 23, 2026 · High confidence | Lapsed on the fee record | Ended Aug 23, 2026 | High confidence |